Wordt geladen...
Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy
The selective delivery of therapeutic radionuclides is a promising approach for treating cancer. Antibody-targeted radionuclides are of particular interest, with two products approved for the treatment of certain forms of non-Hodgkin lymphoma. However, for many other cancers, radioimmunotherapy (RAI...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2855818/ https://ncbi.nlm.nih.gov/pubmed/20350628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semnuclmed.2009.12.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|